BES 2022

14:30-15:45

Symposium 1 (sponsored by Ipsen)
Chair: Guy T’Sjoen (UGhent)

Part 1: Highlights of ECE 

• Focus on neuroendocrine tumors
  Wouter de Herder (NL, Erasmus MC, Amsterdam)
• Focus on acromegaly
  Albert Beckers (ULiège)

Part 2: Innovation for patients with patients
           Mrs S. Llahana (UK, University College of London)

Part 3: Discussion/Q&A

16:00-17:15

• Welcome and introduction
  André Scheen (chair, Belgium)
• What we have learned in almost two decades of incretin treatment. 16:05-16:15
  André Scheen (chair, Belgium)
• GIP and GLP-1, the twin-cretin hormones: Similarities and differences. 16:15-16:35
  Michael Nauck (Germany)
• Novel dual incretin receptor agonists: surpassing standards in diabetes care. 16:35-16:55
  Christophe De Block (Belgium)
• Panel discussion and audience key questions on data presented  16:55-17:10
• Summary and consolidation
  André Scheen (chair, Belgium)

Coffee & visit of the exhibits

Welcome
B. Velkeniers (VUB), president

20:00

Evening symposium
A message from three young emeriti 
Chair: P. Petrossians (ULiège)     

• How do they grow so tall ?
  Albert Beckers (ULiège)
• A 2022 update in the management of prolactinoma
  Dominique Maiter (UCL)
• Immune checkpoint inhibitors and endocrine side effects
  Brigitte Velkeniers (VUB) 

20:00-22:00

Walking diner
Visit of the exhibits & poster viewing

General assembly 
B. Velkeniers (VUB), President

Clinical grand round : hypoparathyroidism
Introduced by o. Alexopoulou (UCL) 

Brigitte Decallonne (KUL) & Bernard Corvilain (ULB)

9:30–10:30

Part 1: Translational and clinical studies
Chair: L. Crenier (ULB)

• Exercise as a non-pharmacological intervention to protect pancreatic beta cells in patients with type 1 and type 2 diabetes.
  

  Alexandra Coomans de Brachène (ULB)
• A plasma miR-193b-365 signature predicts non-responsiveness to Lactococcus lactis-based antigen-specific immunotherapy in new-onset type 1 diabetes.
  Gabriele Sassi (KUL)

• The insulin sensitivity index derived from euglycemic clamps is correlated to liver fat content determined by magnetic resonance spectroscopy in type 1 diabetes .
  Jonathan Mertens (UA)
• Mortality-related risk factors of inpatients with diabetes and COVID-19: a multicentric retrospective study in Belgium
  Thomas Servais (UCL)

10:30–11:00

Part 2: Clinical case reports
Chair: M. Bex (KUL)

• Chromosome 22q11.2 deletion syndrome revealed by severe hypocalcemia and pulseless electric activity: Untangling a conglomerate of potential primary etiologic factors.
  Eric Balti (VITAZ St. Niklaas)
• Is this just vitiligo? Nelson is hiding.
  Maarten De Vis (VUB)

11:45–12:00

Selected Belgian Publication Award (sponsored by Sandoz)
Introduced by C. De Block (UA)

Margaretha Visser et al. The Lancet 2021; 397:2275-2283
Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial.

Presenting author: Margaretha Visser (KUL)

12:00–12:30

Belgian Endocrine Society Lecture Award (sponsored by Novo)
Introduced by B. Velkeniers (VUB), President

Determinants and consequences of sex steroid exposure in men
Award winner: Bruno Lapauw (UGhent) 

12:30-13:00

Invited lecture
Introduced by Patrick Petrossians (Uliège)

Menopauze – 20 years after WHI (Women’s Health Initiative). 
Axelle Pintiaux (ULiège)

Award ceremony young investigators